Big Tech Winning Battle with ‘Patent Trolls’

For two decades, companies that buy software patents to sue technology giants have been the scourge of Silicon Valley. Reviled as patent trolls, they have attacked everything from Google’s online ads to Apple’s iPhone features, sometimes winning hundreds of millions of dollars.

But now the trolls are in retreat from the tech titans, interviews and data reviewed by Reuters show.

In the wake of several changes in U.S. law, which make it easier to challenge software patents, patent prices are plummeting, the number of court fights is down, and stock prices of many patent-holding companies have fallen. Some tech firms say they are punching up research budgets as legal costs shrink, while support for major patent reform is under fire as trolls get trounced.

“Their entire business model relies on intimidation, and that has lost its edge,” said Efrat Kasznik, president of intellectual property consulting firm Foresight Valuation Group. “If the patents are not enforceable in court anymore… the troll has no legs to stand on.”

Brokers who work with the patent acquisition companies acknowledge the new climate.

“In some cases, there are just no current buyers for these patents at all,” said Robert Aronoff, founder of the patent brokerage Pluritas, citing new legal standards for the change.

NetApp a Silicon Valley maker of sophisticated data storage devices, last month used a new legal precedent to force a patent holder to pay its legal fees. The judge called the case “reckless and wasteful.”

The new playing field allows NetApp to spend more on developing its own patents, as opposed to litigation defense. “It is freeing up dollars,” said Douglas Luftman, NetApp’s chief intellectual property counsel.

To be sure, not all litigious patent owning companies are losing ground. Some with court-tested patents are doing well. And not all big tech companies are convinced of the change.

Cisco Systems Inc. has been at the forefront of the fight against infringement lawsuits and has not seen a drop in new suits in recent months, said General Counsel Mark Chandler.

Cisco will continue to push for laws to stop warrantless lawsuits, Chandler said. Others see the need diminishing.

THE BIRTH OF TROLLS

Big tech companies distinguish between their own intellectual property, which they fiercely protect, and those of their adversaries, which they often dismiss as broadly worded and vague, allowing holders to sue all manner of defendants. The big tech companies note that the patent acquisition companies they label as trolls generally make no products but are solely in the business of buying patents and litigating to enforce them.

The putative trolls see a different world. They buy patents from inventors and each other, creating a marketplace that checks big tech companies’ sway, and rely ultimately on a fair arbiter: courts. This can provide vital protection for investors’ ideas, said Matt Vella, CEO of Acacia Research Corp, which contracts with owners to license their patents to other companies. “I see it as a Robin Hood function,” he said.

If the so-called trolls had a birth date, it would be the summer of 1994, when a federal appeals court explicitly allowed computer program patents for the first time.

In the ensuing years, software patents exploded, covering topics from Wi-Fi to one-click shopping. So did patent lawsuits. Last year, more than 6,000 patent suits were filed, according to intellectual property analytics firm Lex Machina. A 2013 White House report said “trolls” were responsible for 60 percent of suits, up from 29 percent in 2010.

Congress struck the first blow against these high-volume plaintiffs in an overhaul of the patent system. Starting in 2012, companies accused of infringement could ask the U.S. Patent and Trademark Office to invalidate patents used in litigation. The reviews are much cheaper and faster than court.

The reviews proved popular — and devastating for many patent owners. As of June, the patent office was invalidating some or all of challenged patents’ claims at a rate of 80 to 90 percent, depending on the type of review.

Then, in June of this year, the Supreme Court unanimously ruled that a basic idea — not normally eligible for a patent — does not become patent-worthy if run on a computer. That case, Alice vs. CLS Bank, has made it easier still to quash software patents, and at least 13 lower court rulings since then have done just that.

MOUNTING EVIDENCE

New federal patent lawsuits last month were down 40 percent from the previous year, to 329 cases, data from Lex Machina show.

Defendants are also fighting longer, driving up costs for the acquisition companies. In 2004, the median time it took for a case that didn’t settle was 467 days. By 2013, that had reached 673 days, according to Lex Machina.

Intellectual Ventures, one of the largest private patent buyers, laid off over 20 percent of its workforce this year. The company began with backing from big tech companies who saw it as an ally, but some longtime investors including Apple and Intel declined to participate in its latest funding round. Intellectual Ventures declined to comment.

A survey of private patent deals compiled by brokerage IPOfferings, found the average price of a patent was $165,000 in the second quarter of 2014, down from $375,000 in 2012.

Some patents have withstood challenges under the new legal rules, however. Marathon Patent Group announced last month that the U.S. government rejected a request by ARM Holdings to invalidate a Marathon patent. Marathon is trading up 28 percent since mid-June.

Michael Friedman, managing director at IP strategy firm Ocean Tomo, said patents on widely used technology owned by companies like IBM, Microsoft and Qualcomm, are still in a strong position to seek licenses.

But some companies whose business model depends on successful litigation have seen their stock slide since Alice, the 2014 Supreme Court case. InterDigital has fallen over 5 percent and Acacia Research Corp  is down over 9 percent. (See graphic: link.reuters.com/rej23w)

Just three weeks after Alice was decided, an Acacia Research subsidiary felt its reach when a federal appeals court backed the revocation of a patent on digital image processing, used to sue over 30 tech firms.

Acacia is appealing and said that in general, its other patents will not be impacted by Alice in the same way, since few deal with the kinds of software methods Alice puts at risk.

Still, Vella, Acacia’s CEO, said, said his company sensed the changing legal landscape and is shifting its strategy, away from one-patent cases to challenges based on several patents.

Article first Published on Reuters

Could the SEC require companies to value their patent portfolios?

Efrat Kasznik Foresight ValuationThe need to value patent portfolios may be even greater after the Supreme Court’s decision in the Alice case.

The Securities and Exchange Commission (SEC) may require more transparency among public companies when it comes to valuing their patent portfolios.

Now, such portfolios generally do not have to be formally valued and reported to interested parties. But given the push for increased transparency, such as at the SEC, and the desire by investors to know more about the companies in which they invest there could be more guidelines or formal requirements forthcoming.

Looking ahead, the need for valuing patent portfolios may be even greater after the Supreme Court’s decision in the Alice Corp. v. CLS Bank case, too. The Alice decision also was seen as a partial victory for many large tech companies that need to protect their patent portfolio from lawsuits, according to InsideCounsel. Generally, in Alice, the justices confirmed that an abstract idea cannot be patented under Section 101 of Title 35 U.S.C. even if a computer is used.

As of now, companies do not calculate the value of their patent portfolio, but will report an amount on patent portfolios that they acquire through M&A activity, according to accounting professionals.

“Intangible assets must be fully disclosed only when they are acquired and paid for, either in a business combination (M&A deal) or in an asset purchase, when the purchased intangibles are valued and reported on the balance sheet of the buyer at their fair value,” Efrat Kasznik, president of the Foresight Valuation Group, explained in a recent article.

Change is possible, however, but it may only come down as a requirement by regulators.

“It needs to come down from the SEC,” Kasznik, a lecturer on valuation at Stanford’s business school, told InsideCounsel in an interview. “I am not sure that companies would voluntarily do that.”

She recommends that companies voluntarily look at the value of their IP portfolio, especially with the heightened attention given to it associated with the Alice decision. Also, this way they would be able to answer any questions on the portfolio’s value that could be posed by shareholders.

“This is not a new problem,” Kasznik added. “Alice made it more acute.”

In connection with the Alice decision, she further recommends that companies undertake a legal review of patent portfolios to see if a significant portion of the portfolio is at risk.

Still, it is understandable why some companies may be opposed to releasing a value on patent portfolios. The values are very volatile, which likely means a company would have to keep on updating the estimates, Kasznik said. Also, now management of a company has more information about a business than the market in general. Management can pick and choose when and what to disclose when it is advantageous for them to do so. And businesses may argue that the strength of a patent portfolio may be able to be interpreted by analysts already by closely examining R&D expenses.

The patent portfolio is considered to be an intangible asset. A rule on these kinds of assets was never implemented largely because of “resistance by reporting entities and their advisors to disclose market vulnerability arising from proprietary rights,” the SEC’s website explained based on collected comments. “In addition, rules were never formalized to guide the reporting of internally generated intangible assets.” Under the U.S.C. 9, “General intangibles” includes such items as “patents, trademarks, copyrights, contracts, permits, executory contracts, and licenses.”

But in recent years, there have been transactions involving collateralization of GI. These include Google’s acquisition of Motorola for $12.5 billion, which included an impressive patent portfolio, or, Nortel selling its patent portfolio for $4.5 billion to Apple, Microsoft and other tech firms.

These are “only a few examples of material obfuscation and carelessness where appropriate recording and transparency would have benefitted shareholders,” according to comments made to the SEC.

Article first published on InsideCounsel

The Impact of the Alice Decision on Corporate Patent Assets

The Impact of the Alice Decision on Corporate Patent AssetsThe Supreme Court’s Alice decision has introduced a dimension of uncertainty associated with the validity of many of the software patents held by operating companies today. There seems to be a consensus among some of the leading academic and judiciary experts supporting that conclusion, as seen in recent comments made by Stanford Law School’s Prof. Mark Lemley, as well as in recent comments by former Federal Circuit Chief Judge Michel. From a valuation and financial reporting perspective, there needs to be a serious examination of the post-Alice landscape implications on the value of patents as corporate assets. The results of such examination may lead to further action – which could range anywhere from additional disclosure requirements by regulators, all the way to actual corporate asset write-offs. This article highlights some of the key issues that need to be addressed by companies and regulators.

Financial Reporting for Intangibles: Overview of Existing Standards

In order to address the Alice decision and its impact on corporate disclosures, one needs to first understand the existing financial reporting requirements and how patents are presented as corporate assets. Under current accounting rules (US-GAAP and IFRS), internally generated intangibles, including patents, do not show as assets on the balance sheets of the companies that created them. Patents only show up on the balance sheet if they were acquired and paid for, either as a standalone portfolio or as part of an M&A deal where the assets of the target include patents. It is important to mention that these patents had no value on the books of the selling company either, so in most cases a transaction where patents are changing hands is the first time that the value of such assets is reported anywhere.

Take, for example, the Google acquisition of Motorola Mobility in 2012. The Motorola Mobility balance sheet on the eve of the acquisition showed virtually no value allocated to patents as corporate assets. Yet, the acquisition resulted in Google reporting $5.5 billion of patents as acquired assets on its post-merger balance sheet. The post-M&A valuation itself is conducted by valuation experts with no particular legal or technical knowledge, who assume that the patents are valid based on the due diligence done by the legal team of the buyers. Assessing the validity of patents as part of a post-merger purchase price allocation is outside the area of expertise of IP valuation experts, as well as the auditors in charge of reporting the deal. Once the pre-merger due diligence is complete, there is no further legal examination of the patents for purposes of financial reporting.

Implications of the Alice Decision on Financial Reporting of Patents

When looking at the financial statements of any company, one needs to keep in mind that there are two types of disclosures for patents: the reported patents, resulting from acquisitions; and the “invisible” patents, those emerging from the company’s own R&D efforts, which are not reported as corporate assets as all. It is usually the case that most of the company’s patents fall under the second category, and in particular when it comes to large tech companies that spends billions of dollars on R&D, resulting in many new patents filed every year.

There is an established process for recording losses related to the decline in value of patents acquired through acquisitions: these patents are tested periodically for “impairment”, a process that involves comparing the carrying amount of an asset (price paid for the asset, or its “book value”) to its fair value (as calculated based on current market conditions). An impairment loss is recognized when the carrying amount of patents is not recoverable and exceeds its fair value. Impairment testing is done when there is an indication that might trigger a decrease in the market price of the asset below its reported book value. There is a list of conditions that the regulators consider as triggers for impairment, including – among others – a significant adverse change in legal factors. It is a grey area involving discretion by management, subject to varying degrees of leniency by the auditors running these impairment tests. It is not immediately clear whether the post-Alice legal ambiguity should be considered a strong enough trigger for impairment testing of certain categories of patents, and if so, what type of testing should be applied, and who should perform the testing. Impairment testing is currently done by valuation experts who lack the legal background to assess the validity risk associated with the patents, and subsequently the assumption of validity is carried over from the original post-merger valuation. More guidance is needed from the FASB and the SEC on that topic since the process, as currently performed, does not lend itself to the inclusion of validity assessment by the valuation experts or the auditors.

While impairment analysis exists for reported intangible, there is no process whatsoever for writing off non-reported intangibles, which include all internally created patents as previously discussed. Since these assets are not on the balance sheet, there is nothing to write off in the first place and no basis against which to conduct an impairment test. From a pure accounting perspective – there is no place to record the loss, and no way to calculate the size of the loss. This does not mean that the markets will not factor that into the stock price, even without specific disclosure by the company. It may very well be that if companies start writing off acquired intangibles, stock analysts and investors could estimate the degree at which a similar write-off could be applied to non-reported patents, and adjust stock price expectations accordingly. While this is all highly speculative and there is no way of telling how stock markets will react, it is not unreasonable to assume that some companies with patents that are directly impacted by the Alice decision might see some sort of market price adjustment based on the higher invalidity risk associated with these assets, even if these patents are not on the balance sheets of these companies.

Implications of the Alice Decision on Compliance with Securities Laws

Financial reporting is the main channel for companies to communicate information to shareholders and markets at large. Financial reporting by US publicly traded companies is regulated by the SEC, and is governed by a set of securities laws and regulations. One should therefore look up to the SEC for guidance related to the post-Alice disclosure requirements to be imposed on companies. More specifically, both Sarbanes-Oxley (SOX) Act as well as Rule 10b-5 compliance are issues that warrant a closer look:

The Sarbanes-Oxley (SOX) Act requires management and auditors to establish a level of internal controls that would guarantee the accuracy of reported financial statements. All financial reports need to include an Internal Controls Report showing that a company’s financial data are accurate and that adequate controls are in place. Criminal and civil penalties are imposed for noncompliance. Section 302 requires the CEO and CFO to certify that the reports “fairly present in all material respects the financial condition and results of operations” of the company for the periods included in the report. When it comes to IP, the guidelines for SOX compliance are vague and there’s no clear set of steps that companies apply to their IP portfolio to guarantee compliance. This approach might change post-Alice, if large portfolios are at risk of invalidity. It could certainly be considered a “material aspect” yet it is unclear what set of best practices will emerge and how the SEC will enforce them.
The 1934 Securities Exchange Act’s rule 10b-5 lays the foundation for the SEC to investigate possible security fraud claims. Rule 10b-5 violations cover cases where executives make false statements in order to drive up share prices, or where they withhold negative information that could have an adverse impact on stock prices. Violations of 10b-5 open the door to shareholders’ class action litigation as well, especially if stock prices experience fluctuations that can be attributed to material misrepresentations by management. This could create an additional risk of litigation or SEC investigation for companies with a large concentration of patents directly affected by Alice, and should motivate these companies to take a closer look at the value of their IP portfolio and determine whether additional disclosures are prudent under the circumstances.

Article first published on IPWatchDog

Crowdfunding Update: IP Protection and Startup Valuation Considerations

Mary Juetten, CEO of Traklight and Efrat Kasznik, Foresight Valuation

Crowdfunding is expected to become a leading source of financing in the early stage, on both rewards and equity platforms. It is likely to add more transparency to startup valuations and, at the same time, contribute to an upward trend in valuations. However, the lack of attention to IP protection or infringement during the campaign can have negative implications on the valuation of your startup. The topic of IP protection should therefore be top of mind for entrepreneurs engaged in crowdfunding, as it is critical to their survival and success long after the campaign has ended.

Read the full article here .

Proudly powered by WordPress | Foresight theme designed by thingsym